Overview of the 340B Rebate Pilot Program
The Trump administration has officially approved eight drugmakers’ rebate plans for a controversial 340B drug discount pilot program launching January 1, 2025. This groundbreaking initiative, unveiled earlier this…
HRSA is scheduled to issue approvals to drugmakers by Oct. 15 for implementation of the pilot on Jan. 1, 2026.In July, the Health Resources and Services Administration announced the availability of a voluntary 340B…
Continue Reading
The “Meet Mark” Campaign Strategy
The pharmaceutical lobby has intensified its opposition to nonprofit health systems’ expanding use of the 340B Drug Discount program through a sophisticated advertising campaign. The Pharmaceutical Research and Manufacturers of…
Introduction
The healthcare industry is facing a significant policy shift that could fundamentally alter how hospitals access discounted medications. With critical deadlines rapidly approaching, the American Hospital Association (AHA) has intensified its opposition to a…
Overview of the 340B Rebate Pilot Program
The Trump administration has introduced a controversial 340B rebate pilot program that is generating significant pushback from hospital and health system groups nationwide. This initiative represents a fundamental…
What You Should Know:
– Proximity, the intelligent automation platform maximizing 340B drug discount revenue for qualified healthcare providers, launched today with $3 million in funding to help uncover and secure revenue critical to operating…
Continue Reading
Bluesight, the leading provider of Medication Intelligence solutions for health systems and hospital pharmacies, announced the acquisition of Sectyr, a top-tier compliance and audit management platform. This acquisition expands Bluesight’s portfolio to include robust…
Continue Reading
August brought some exciting new data and publications from KLAS. Included in this month’s reports are an executive overview of KLAS’ fifth Enterprise Imaging Summit, a recap report of the Emerging Insights that KLAS…
Continue Reading
The 340B program is a significant driver of savings and improved profit margins for health systems—for many organizations, the inclusion of a 340B program can even be the factor that makes them financially viable….
Continue Reading
This week, the Centers for Medicare & Medicaid Services finalized updates to its physician fee schedule for 2024, as well as finalized the rule for next year’s Outpatient Prospective Payment System (OPPS).
The federal agency…
